Perlara in the news
November 1, 2017
Perlara Announces $7.4M Equity Financing
January 31, 2017
Perlara Announces Third Patient Advocacy Group Partnership
January 10, 2017
Perlara PBC Announces Patient Advocacy Group Partnerships
July 31, 2014
Perlstein Lab Seed Round
The latest from our Blog
What the NGLY1 community can learn from the humble fly On the first day of the new year, we submitted a new NGLY1 model preprint entitled “Defects in the neuroendocrine axis cause global developmental delay in a Drosophila model of NGLY1 Deficiency.” Follow on...
Comparative fly model studies of NGLY1 Deficiency Earlier this week I was alerted on Twitter (where else?) to a new NGLY1 paper from Dr. Clement Chow’s lab at the University of Utah entitled: “Transcriptome and functional analysis in a Drosophila model of NGLY1...
When we last checked in a year ago, Perlara had just achieved three critical milestones: a product (PerlQuest), a validating Pharma deal, and first revenue - a small check, but revenue nonetheless. Over the course of 2017, we transitioned from startup with a...